Skye Bioscience (SKYE) Shares Rise 6% After Hours: Here's What's Driving The Move
Skye Bioscience shares rise 6% after hours on a $22M equity purchase agreement and warrant issuance.
Read original at benzingaStocks · News reference
8-K filing — Skye Bioscience, Inc. (SKYE)
Filed: 2026-08-14 AccNo: 0001628280-26-056966 Size: 7 MB Item 1.01: Entry into a Material Definitive Agreement Item 3.02: Unregistered Sales of Equity Securities Item 3.03: Material Modifications to Rights of Security Holders Item 5.01: Changes in Control of Registrant Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers Item 5.03: Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year Item 7.01: Regulation FD Disclosure Item 9.01: Financial Statements and Exhibits
Reference details
Connected markets
Poisar stores the source's headline, summary and market tags for reference. Reporting and full article text remain with the original publisher.
- Source
- edgar
- Observed
- Aug 14, 2026, 1:36 PM
- Checked
- Aug 14, 2026, 1:36 PM
- Cadence
- Captured once, then retained as an archive reference
- Status
- fresh
Keep reading
Related headlines
Skye Bioscience Enters Into Securities Purchase Agreement With Redmile Affiliate For Aggregate Purchase Price Of Up To $22M
Entry into a Material Definitive Agreement. As previously disclosed on the Current Report on Form 8-K filed by Skye Bioscience, Inc., a Nevada corporation (the "Company"), with the U.S. Securities and Exchange
Read original at benzinga8-K filing — Skye Bioscience, Inc. (SKYE)
Filed: 2026-08-24 AccNo: 0001628280-26-058605 Size: 801 KB Item 1.01: Entry into a Material Definitive Agreement Item 3.02: Unregistered Sales of Equity Securities Item 9.01: Financial Statements and Exhibits
Read original at edgarTrading Halt: Halted at 7:50:00 p.m. ET - Trading Halt: Halt News Pending
Read original at benzinga